Thermo Fisher Scientific (TMO) in Pivotal Point Check: Laboratory Supplier Delivers Strong Q2 Numbers and Upgrades Annual Revenue and Profit Forecast!
Reading Time: 2 minutes
Strong quarterly results: The company significantly exceeds expectations for revenue and profit in Q2 2026. Revitalization in the pharmaceutical industry: A noticeable recovery in the biotech sector leads to 5% organic revenue growth. Upgrade of annual forecast: Management raises outlooks; Jefferies increases target price to $630. Thermo Fisher Scientific provides laboratory supplies, analytical instruments, and services in the life sciences. The stock rose more than 8% on July 23 after the release of Q2 numbers, peaking at over $587. This...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
